National Guideline Clearinghouse | Aflibercept for treating diabetic macular oedema.

FULL-TEXT ►

National Guideline Clearinghouse | Aflibercept for treating diabetic macular oedema.

National Institute for Health and Care Excellence (NICE)

Guideline Title

Aflibercept for treating diabetic macular oedema.

Bibliographic Source(s)

National Institute for Health and Care Excellence (NICE). Aflibercept for treating diabetic macular oedema. London (UK): National Institute for Health and Care Excellence (NICE); 2015 Jul. 46 p. (Technology appraisal guidance; no. 346).

Guideline Status

This is the current release of the guideline.

This guideline meets NGC's 2013 (revised) inclusion criteria.